Congratulations Vishal Swaminathan representing Mayo Clinic Department of Ophthalmology and all other awardees!

DRCR's Protocol AC primary results from NEJM nejm.org/doi/full/10.10… as a top 10 Ophtho Article of the Last Year blog.doximity.com/articles/the-t…

Mayo Clinic Department of Ophthalmology congratulates all of our graduating #Residents and #Fellows! Andrew Barkmeier MD Andrea A. Tooley, MD Rachel Mogil Saumya Shah, M.D. Marybeth K. Farazdaghi, M.D. #MaudeAndersonMN #BlakeFortesMD #AliSalamanMD #AhmedSheikhMD #LulwaElZeinMD #TaylorNaymanMD #NegarMohebMD

👨‍⚕️ “… and you shouldn’t lift anything heavy for the next week” “What about my pet raccoon? She’s about 40 pounds.” 👨‍⚕️“oh… really… yeah, not this week”

No significant diurnal variation in optical coherence tomography-based macular fluid or thickness was identified in patients w/ exudative age-related macular degeneration per Andrew Barkmeier MD Aaron Fairbanks MD in International Journal of Retina and Vitreous. bit.ly/47eptM1

Our Ophthalmology study, Expert vs #LLM vs Expert-edited LLM responses to Retina questions: -Expert-edited LLM > Expert responses in quality & empathy -Expert placed 4/7 quality & 6/7 empathy -⏱️ savings for Expert-edited vs Expert responses #AI #ChatGPT tinyurl.com/4sv2kpmb

New study looks at the comparative effectiveness of GLP-1 receptor agonists, SGLT2 inhibitors, DPP-4 inhibitors, and sulfonylureas for sight-threatening #diabeticretinopathy. Andrew Barkmeier MD Rozalina (Grubina) McCoy, MD MS ow.ly/MykX50RMZtO

Importance of including metastatic disease in the differential diagnosis of new visual floaters, blurred vision & other common ocular symptoms in patients with a history of cancer per Aaron Fairbanks MD Diva R. Salomao, MD & Andrew Barkmeier MD in American Journal of Ophthalmology. bit.ly/4e6nqxk

Congrats to John J. Chen, MD, PhD and Elias Sotirchos on securing $10M The Patient-Centered Outcomes Research Institute funding to conduct a randomized clinical trial on early plasma exchange for severe optic neuritis and transverse myelitis (TIMELY-PLEX). w/ Johns Hopkins Medicine Mayo Clinic Neuro bit.ly/4gjz3CT

Informative original article by Andrew Barkmeier MD et al on Comparative Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter 2 Inhibitors, Dipeptidyl Peptidase-4 Inhibitors, and Sulfonylureas for Sight-Threatening Diabetic Retinopathy.

Tonight I gave my final presentation on the ⁦referendum for Rochester schools and here’s a short final video that I hope you’ll watch and share. We have done all we can to explain what’s at stake, and now it’s time for the people of Rochester to decide. youtu.be/b7edFAoSosU

jamanetwork.com/journals/jamao…

Catch up on the top ten Mayo Clinic Department of Ophthalmology podcasts from 2024! w/ Dr. Erick Bothun Andrea A. Tooley, MD Andrew Barkmeier MD Matt Starr, MD Lilly Wagner John J. Chen, MD, PhD MichaelMahrMD mayocl.in/40KkYZd

With over 2,000 views to date: Reeda Bou Said, M.D. & Andrew Barkmeier MD present a case of bilateral perifoveal atrophy in a 46-year-old woman who was referred for a second opinion regarding hydroxychloroquine retinal toxicity in JAMA Ophthalmology. bit.ly/4hsRcyp

This retrospective study suggests a modestly increased risk of nonarteritic anterior ischemic optic neuropathy (NAION) in patients with type 2 diabetes using semaglutide. ja.ma/4k9o2Gc

Ophthalmology notes are full of acronyms - “CME, PPV, NAION." In our Mayo Clinic randomized QI study, we added plain language summaries and tested them in real care settings. 85% of non-eye clinicians preferred Opthalmology notes with an AI-generated summary. #MedTwitter #AI #LLM